960化工网
Targeted delivery of a novel peptide–docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel†
Abhijit Saha,Saswat Mohapatra,Prashant Kurkute,Batakrishna Jana,Jayita Sarkar,Prasenjit Mondal
RSC Advances Pub Date : 10/22/2015 00:00:00 , DOI:10.1039/C5RA16741H
Abstract

We have designed a novel peptide–docetaxel conjugate, which delivers docetaxel specifically to cancer cell targeting neuropilin-1 (NRP-1) receptor, thus enhancing its efficacy and acts more aggressively in breast cancer cells.

Graphical abstract: Targeted delivery of a novel peptide–docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel
平台客服
平台客服
平台在线客服